CD4 and type 1 diabetes mellitus: As T1D is known to be driven by increased oxidative stress [3, 34], our laboratory has demonstrated that inhibition of ROS during immune activation results in dampened CD4+ T cell responses, thus inhibiting T1D progression [35–38].